Track the 한올바이오파마 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 한올바이오파마 has recorded 37 public disclosures. The latest transaction was reported on 1 July 2026 (Purchase). Among the most active insiders: 국민연금공단. All data is accessible without an account.
37
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
13 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.